The NIHR DEC Leeds facilitates the generation of high quality evidence on in vitro diagnostic medical devices (IVDs) for use in the NHS.

By working with patients, commercial and non-commercial partners and NHS commissioners we evaluate protein and cellular marker IVDs for their clinical validity, utility, cost-effectiveness and ability to change practice and improve outcomes.

Our strategic aims are to:
  • devise and refine methods in IVD study designs, health economics and health informatics to improve and speed up the way IVDs can be evaluated for NHS use
  • invite, select and prioritise specific IVD candidates in our clinical areas, from partners and interested parties and help them develop and deliver appropriate evidence
  • sustain our working networks of co-operating NHS sites to deliver studies effectively with their patients and samples
  • create a strong stakeholder engagement group to work with our teams and patients to shape our strategies, research programmes and projects and identify new opportunities together.

Our areas of expertise:

  • Urological diseases
  • Liver diseases
  • Musculoskeletal diseases
  • Colorectal diseases
  • Oncology (breast, colorectal, urological and liver cancers)
  • Study and trial design
  • Health economics
  • Health Informatics
    IVD validation:
  • Clinical biochemistry
  • Quality assurance
  • Proteomics